AAAAAA

   
Results: 1-8 |
Results: 8
Oncodiagnosis panel: 1999 cancer of the lung: Oncodiagnosis
Authors: Komaki, R Chasen, MH Travis, WD Putnam, JB Fossella, FV Byhardt, RW Ro, JY
Citation: R. Komaki et al., Oncodiagnosis panel: 1999 cancer of the lung: Oncodiagnosis, RADIOGRAPHI, 21(6), 2001, pp. 1573-1596
Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC):Identification of five groups with different survival
Authors: Werner-Wasik, M Scott, C Cox, JD Sause, WT Byhardt, RW Asbell, S Russell, A Komaki, R Lee, JS
Citation: M. Werner-wasik et al., Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC):Identification of five groups with different survival, INT J RAD O, 48(5), 2000, pp. 1475-1482
Anal sphincter conservation for patients with adenocarcinoma of the distalrectum: Long-term results of Radiation Therapy Oncology Group Protocol 89-02
Authors: Russell, AH Harris, J Rosenberg, PJ Sause, WT Fisher, BJ Hoffman, JP Kraybill, WG Byhardt, RW
Citation: Ah. Russell et al., Anal sphincter conservation for patients with adenocarcinoma of the distalrectum: Long-term results of Radiation Therapy Oncology Group Protocol 89-02, INT J RAD O, 46(2), 2000, pp. 313-322
Toxicities in RTOG combined-modality trials for inoperable non-small-cell lung cancer
Authors: Byhardt, RW
Citation: Rw. Byhardt, Toxicities in RTOG combined-modality trials for inoperable non-small-cell lung cancer, ONCOLOGY-NY, 13(10), 1999, pp. 116-120
Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the Radiation Therapy Oncology Group experience
Authors: Machtay, M Seiferheld, W Komaki, R Cox, JD Sause, WT Byhardt, RW
Citation: M. Machtay et al., Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the Radiation Therapy Oncology Group experience, INT J RAD O, 44(4), 1999, pp. 847-853
Interfraction interval does not affect survival of patients with non-smallcell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: A multivariate analysis of 1076 RTOG patients
Authors: Werner-Wasik, M Scott, C Graham, ML Smith, C Byhardt, RW Roach, M Andras, EJ
Citation: M. Werner-wasik et al., Interfraction interval does not affect survival of patients with non-smallcell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: A multivariate analysis of 1076 RTOG patients, INT J RAD O, 44(2), 1999, pp. 327-331
Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): Analysis of radiation therapy oncology group (RTOG) trials
Authors: Cox, JD Scott, CB Byhardt, RW Emami, B Russell, AH Fu, KK Parliament, MB Komaki, R Gaspar, LEW
Citation: Jd. Cox et al., Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): Analysis of radiation therapy oncology group (RTOG) trials, INT J RAD O, 43(3), 1999, pp. 505-509
Dose escalation for non-small cell carcinoma of the lung before 3D conformal radiation therapy: long-term observations of normal tissues from RTOG protocol 83-11
Authors: Cox, JD Scott, CB Smith, C Phillips, TL Emami, B Byhardt, RW Slater, JM Asbell, SO Hartsell, WF
Citation: Jd. Cox et al., Dose escalation for non-small cell carcinoma of the lung before 3D conformal radiation therapy: long-term observations of normal tissues from RTOG protocol 83-11, TREATMENT OPTIMIZATION FOR LUNG CANCER, 1998, pp. 151-156
Risultati: 1-8 |